CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
Summary
Charles River Laboratories International, Inc. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q1 2011 to Q3 2024.
  • Charles River Laboratories International, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending September 28, 2024 was $146M, a 431% increase year-over-year.
  • Charles River Laboratories International, Inc. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending September 28, 2024 was $499M, a 17.2% decline year-over-year.
  • Charles River Laboratories International, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was $540M, a 38.9% increase from 2022.
  • Charles River Laboratories International, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2022 was $389M, a 6.52% increase from 2021.
  • Charles River Laboratories International, Inc. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2021 was $365M, a 9.5% decline from 2020.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $499M $146M +$119M +431% Jun 30, 2024 Sep 28, 2024 10-Q 2024-11-06
Q2 2024 $380M $74.3M -$53.6M -41.9% Mar 31, 2024 Jun 29, 2024 10-Q 2024-08-07
Q1 2024 $434M $19.5M -$107M -84.6% Dec 31, 2023 Mar 30, 2024 10-Q 2024-05-09
Q4 2023 $540M $259M -$62.2M -19.4% Oct 1, 2023 Dec 30, 2023 10-K 2024-02-14
Q3 2023 $602M $27.6M +$68.2M Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $534M $128M +$102M +398% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-07
Q1 2023 $432M $126M +$43.2M +52.2% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-09
Q4 2022 $389M $321M +$215M +204% Sep 25, 2022 Dec 31, 2022 10-K 2024-02-14
Q3 2022 $174M -$40.6M -$119M -152% Jun 26, 2022 Sep 24, 2022 10-Q 2023-11-08
Q2 2022 $293M $25.7M -$81.7M -76.1% Mar 27, 2022 Jun 25, 2022 10-Q 2023-08-09
Q1 2022 $375M $82.8M +$9.44M +12.9% Dec 26, 2021 Mar 26, 2022 10-Q 2023-05-11
Q4 2021 $365M $106M -$94M -47.1% Sep 26, 2021 Dec 25, 2021 10-K 2024-02-14
Q3 2021 $459M $78.7M -$41.7M -34.6% Jun 27, 2021 Sep 25, 2021 10-Q 2022-11-02
Q2 2021 $501M $107M +$33.8M +45.9% Mar 28, 2021 Jun 26, 2021 10-Q 2022-08-03
Q1 2021 $467M $73.4M +$63.5M +643% Dec 27, 2020 Mar 27, 2021 10-Q 2022-05-04
Q4 2020 $403M $200M +$119M +147% Sep 27, 2020 Dec 26, 2020 10-K 2023-02-22
Q3 2020 $285M $120M +$59.8M +98.7% Jun 28, 2020 Sep 26, 2020 10-Q 2021-11-03
Q2 2020 $225M $73.6M +$33.3M +82.8% Mar 29, 2020 Jun 27, 2020 10-Q 2021-08-04
Q1 2020 $192M $9.87M -$55.2M -84.8% Dec 29, 2019 Mar 28, 2020 10-Q 2021-05-04
Q4 2019 $247M $80.8M +$34.4M +74.1% Sep 29, 2019 Dec 28, 2019 10-K 2022-02-16
Q3 2019 $212M $60.6M +$6.05M +11.1% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-09
Q2 2019 $206M $40.3M +$15.7M +64.1% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-05
Q1 2019 $191M $65M -$11.2M -14.7% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-07
Q4 2018 $202M $46.4M +$37.7M +431% Sep 30, 2018 Dec 29, 2018 10-K 2021-02-17
Q3 2018 $164M $54.5M -$23M -29.6% Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-06
Q2 2018 $187M $24.6M -$63.1M -72% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-31
Q1 2018 $250M $76.2M +$17.7M +30.3% Dec 31, 2017 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $232M $8.73M +$52.1M Oct 1, 2017 Dec 30, 2017 10-K 2020-02-11
Q3 2017 $180M $77.5M +$55.3M +249% Jul 2, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $125M $87.7M +$59.8M +215% Apr 2, 2017 Jul 1, 2017 10-Q 2018-08-08
Q1 2017 $65.2M $58.5M +$28.6M +95.9% Jan 1, 2017 Apr 1, 2017 10-Q 2018-05-10
Q4 2016 $36.5M -$43.3M -$60.5M -353% Sep 25, 2016 Dec 31, 2016 10-K 2019-02-13
Q3 2016 $97M $22.2M +$15.2M +220% Jun 26, 2016 Sep 24, 2016 10-Q 2017-11-09
Q2 2016 $81.8M $27.8M -$39.1M -58.4% Mar 27, 2016 Jun 25, 2016 10-Q 2017-08-09
Q1 2016 $121M $29.9M +$32.8M Dec 27, 2015 Mar 26, 2016 10-Q 2017-05-10
Q4 2015 $88M $17.1M +$46.6M Sep 27, 2015 Dec 26, 2015 10-K 2018-02-13
Q3 2015 $41.4M $6.94M +$6.77M +3960% Jun 28, 2015 Sep 26, 2015 10-Q 2016-11-02
Q2 2015 $34.7M $66.9M +$18.5M +38.2% Mar 29, 2015 Jun 27, 2015 10-Q 2016-08-03
Q1 2015 $16.2M -$2.96M -$30.9M -111% Dec 28, 2014 Mar 28, 2015 10-Q 2016-05-04
Q4 2014 $47.1M -$29.4M -$55.8M -211% Sep 28, 2014 Dec 27, 2014 10-K 2017-02-14
Q3 2014 $103M $171K -$48M -99.6% Jun 29, 2014 Sep 27, 2014 10-Q 2015-11-04
Q2 2014 $151M $48.4M +$26.9M +125% Mar 30, 2014 Jun 28, 2014 10-Q 2015-07-30
Q1 2014 $124M $28M +$22.5M +414% Dec 29, 2013 Mar 29, 2014 10-Q 2015-04-30
Q4 2013 $102M $26.4M +$17M +179% Sep 29, 2013 Dec 28, 2013 10-K 2016-02-12
Q3 2013 $84.6M $48.2M +$12.9M +36.4% Jun 30, 2013 Sep 28, 2013 10-Q 2014-10-30
Q2 2013 $71.7M $21.5M +$1.52M +7.63% Mar 31, 2013 Jun 29, 2013 10-Q 2014-08-07
Q1 2013 $70.2M $5.44M -$29.1M -84.2% Dec 30, 2012 Mar 30, 2013 10-Q 2014-04-30
Q4 2012 $99.3M $9.46M +$3.73M +65% Sep 30, 2012 Dec 29, 2012 10-K 2015-02-17
Q3 2012 $95.6M $35.3M +$29.7M +526% Jul 1, 2012 Sep 29, 2012 10-Q 2013-10-30
Q2 2012 $65.9M $20M -$9.61M -32.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 $75.5M $34.5M -$5.03M -12.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $80.5M $5.73M Sep 25, 2011 Dec 31, 2011 10-K 2014-02-25
Q3 2011 $5.65M Jun 26, 2011 Sep 24, 2011 10-Q 2012-11-01
Q2 2011 $29.6M Mar 27, 2011 Jun 25, 2011 10-Q 2012-08-07
Q1 2011 $39.6M Dec 26, 2010 Mar 26, 2011 10-Q 2012-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.